| Today, Sun, Dec 6, 2009 | | • | Better Biotech Buy: Celgene or Genzyme?
at Motley Fool (Sun 12:11am)
| | Thu, Dec 3, 2009 | | • | SeaChange, Tenet: Early Volume Plays
at TheStreet.com (Thu, Dec 3)
| | • | Coverage initiated on Novavax by Global Hunter Securities
Briefing.com (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | • | Equities Update: Flat Finish as Energies Weigh
at Seeking Alpha (Wed, Dec 2)
| | • | Biotech Stocks: Dyax, Santarus, CytRx soar; Hemispherx craters
at MarketWatch (Wed, Dec 2)
| | • | Biotech Stocks: Dyax rockets, Hemispherx craters on FDA updates
at MarketWatch (Wed, Dec 2)
| | • | NOVAVAX INC Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Wed, Dec 2)
| | • | UPDATE - Novavax says H1N1 flu vaccine shows positive results
at Reuters (Wed, Dec 2)
| | • | Novavax Shares Get Boost On Favorable Vaccine Test Results
at Fox Business (Wed, Dec 2)
| | • | Dyax, RF Micro: Early Volume Plays
at TheStreet.com (Wed, Dec 2)
| | • | Novavax swine flu vaccine meets study goal
AP (Wed, Dec 2)
| | • | NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
PR Newswire (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | • | NOVAVAX INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Dec 1)
| | • | Anthracite, Netlist: Early Volume Plays
at TheStreet.com (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | • | NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
PR Newswire (Mon, Nov 30)
| | • | Biotech Stocks: Drug stocks split; Theravance slides on setback
at MarketWatch (Mon, Nov 30)
| | • | Clarient, Sequenom: Early Volume Plays
at TheStreet.com (Mon, Nov 30)
| | • | NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults
PR Newswire (Mon, Nov 30)
| | Fri, Nov 20, 2009 | | • | [$$] Penn Virginia, MTS Systems and Wet Seal Post Declines
at The Wall Street Journal Online (Fri, Nov 20)
| | • | Novavax to Hold Public Offering of Common Stock
at Fox Business (Fri, Nov 20)
|
Add NVAX News to My Yahoo!:
 
| |
|
0.22% Nasdaq 
Headlines
